Conditions: Indolent or Intermediate Grade B-cell Malignancy
Keywords: Hypersensitivity Reactions B-cell malignancies
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 52
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the feasibility of a 60 minute rapid infusion rituximab protocol in the institution's outpatient infusion center.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Rituximab
Intervention descriptions: intervention 1: Dose 2 of Rituximab IVPB will be started at a rate of 100 mg/hr for the first 15 minutes. If tolerated, the remainder of the bag will be infused over 45 minutes.

Protocol document: